Search research articles
Contact Us
Filters
Showing results (71-80 of 108) with videos related to
Page
of 11
Sort By:
Cancer Genomics & Proteomics
|
December 27, 2024
Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors
Tomoyuki Ishiguro, Kazuyuki Takeda, Daisuke Takayanagi, et al.
Medicine
|
January 14, 2022
A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case report
Kazuyuki Hamada, Kiyoshi Yoshimura, Kazuhiko Oshinomi, et al.
Biomedicines
|
December 24, 2021
Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 Antibodies
Ryotaro Ohkuma, Katsuaki Ieguchi, Makoto Watanabe, et al.
Frontiers in Immunology
|
December 29, 2025
Vinegar intake in patients undergoing immune checkpoint inhibitor therapy: food frequency questionnaire study
Hirotsugu Ariizumi, Miyuki Shimazui, Chisato Ogawa, et al.
Frontiers in Oncology
|
October 28, 2024
Chemotherapy combined with immune checkpoint inhibitors may overcome the detrimental effect of high neutrophil-to-lymphocyte ratio prior to treatment in esophageal cancer patients
Yuya Hirasawa, Yutaro Kubota, Emiko Mura, et al.
Anticancer Research
|
July 26, 2024
Maximum Efficacy of Immune Checkpoint Inhibitors Occurs in Esophageal Cancer Patients With a Low Neutrophil-to-Lymphocyte Ratio and Good Performance Status Prior to Treatment
Yuya Hirasawa, Yutaro Kubota, Emiko Mura, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 26, 2013
Combined treatment effects of radiation and immunotherapy: studies in an autochthonous prostate cancer model
Satoshi Wada, Timothy J Harris, Erik Tryggestad, et al.
Cancers
|
July 29, 2025
Plasma WFDC2 (HE4) as a Predictive Biomarker for Clinical Outcomes in Cancer Patients Receiving Anti-PD-1 Therapy: A Pilot Study
Makoto Watanabe, Katsuaki Ieguchi, Takashi Shimizu, et al.
Biomedicines
|
December 30, 2025
Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective Study
Risako Suzuki, Ryotaro Ohkuma, Makoto Watanabe, et al.
Frontiers in Oncology
|
July 29, 2025
Elevated plasma levels of WAP four-disulfide core domain 2 as a potential prognostic biomarker for various cancers
Makoto Watanabe, Katsuaki Ieguchi, Nobuyuki Onishi, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 108) with videos related to
Sort By:
Page
of 11
Cancer Genomics & Proteomics
|
December 27, 2024
Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors
Tomoyuki Ishiguro, Kazuyuki Takeda, Daisuke Takayanagi, et al.
Medicine
|
January 14, 2022
A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case report
Kazuyuki Hamada, Kiyoshi Yoshimura, Kazuhiko Oshinomi, et al.
Biomedicines
|
December 24, 2021
Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 Antibodies
Ryotaro Ohkuma, Katsuaki Ieguchi, Makoto Watanabe, et al.
Frontiers in Immunology
|
December 29, 2025
Vinegar intake in patients undergoing immune checkpoint inhibitor therapy: food frequency questionnaire study
Hirotsugu Ariizumi, Miyuki Shimazui, Chisato Ogawa, et al.
Frontiers in Oncology
|
October 28, 2024
Chemotherapy combined with immune checkpoint inhibitors may overcome the detrimental effect of high neutrophil-to-lymphocyte ratio prior to treatment in esophageal cancer patients
Yuya Hirasawa, Yutaro Kubota, Emiko Mura, et al.
Anticancer Research
|
July 26, 2024
Maximum Efficacy of Immune Checkpoint Inhibitors Occurs in Esophageal Cancer Patients With a Low Neutrophil-to-Lymphocyte Ratio and Good Performance Status Prior to Treatment
Yuya Hirasawa, Yutaro Kubota, Emiko Mura, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 26, 2013
Combined treatment effects of radiation and immunotherapy: studies in an autochthonous prostate cancer model
Satoshi Wada, Timothy J Harris, Erik Tryggestad, et al.
Cancers
|
July 29, 2025
Plasma WFDC2 (HE4) as a Predictive Biomarker for Clinical Outcomes in Cancer Patients Receiving Anti-PD-1 Therapy: A Pilot Study
Makoto Watanabe, Katsuaki Ieguchi, Takashi Shimizu, et al.
Biomedicines
|
December 30, 2025
Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective Study
Risako Suzuki, Ryotaro Ohkuma, Makoto Watanabe, et al.
Frontiers in Oncology
|
July 29, 2025
Elevated plasma levels of WAP four-disulfide core domain 2 as a potential prognostic biomarker for various cancers
Makoto Watanabe, Katsuaki Ieguchi, Nobuyuki Onishi, et al.
Page
of 11